Metsera, Inc.

Biotechnology • Healthcare • New York, NY, United States • MTSR (NMS)

Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York. As of November 13, 2025, Metsera, Inc. operates as a subsidiary of Pfizer Inc.

212 784 6595 3 World Trade Center, New York, NY 10007, United States

Stock Performance (90 Days)

Data through Nov 13, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Can MTSR stock deliver consistent earnings growth - 2025 Big Picture & Low Drawdown Trading Strategies - moha.gov.vn

moha.gov.vn • Dec 30

Metsera falls after accepting up to $10 billion offer from Pfizer - Reuters

Reuters • Nov 10

Understanding Momentum Shifts in (MTSR) - Stock Traders Daily

Stock Traders Daily • Dec 28

Why Metsera's Share Price Is Plummeting This Week - The Motley Fool

The Motley Fool • Nov 12

Metsera again chooses Novo as bidding war with Pfizer intensifies - BioPharma Dive

BioPharma Dive • Nov 4

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Metsera, Inc. had layoffs?

No layoff events have been recorded for Metsera, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Metsera, Inc. have?

Metsera, Inc. has approximately 125 employees.

What industry is Metsera, Inc. in?

Metsera, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Metsera, Inc. a publicly traded company?

Yes, Metsera, Inc. is publicly traded under the ticker symbol MTSR on the NMS. The company has a market capitalization of approximately $7.43 billion.

Where is Metsera, Inc. headquartered?

Metsera, Inc. is headquartered in New York, NY, United States at 3 World Trade Center, New York, NY 10007, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.